+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intraocular Lens (IOL) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 155 Pages
  • July 2023
  • Region: Global
  • GlobalData
  • ID: 5659891
The publisher's Medical Devices sector report, 'Intraocular Lens (IOL) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Intraocular Lens (IOL) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Intraocular lens is an artificial lens made of plastic, silicone, acrylic or other material that is implanted inside the eye during cataract surgery.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Intraocular Lens (IOL) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Intraocular Lens (IOL) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Intraocular Lens (IOL) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Intraocular Lens (IOL) Overview
3 Products under Development
3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development
3.2 Intraocular Lens (IOL) - Pipeline Products by Segment
3.3 Intraocular Lens (IOL) - Pipeline Products by Territory
3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials
4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies
4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development
5 Intraocular Lens (IOL) Companies and Product Overview6 Intraocular Lens (IOL)- Recent Developments7 Appendix
List of Tables
  • Intraocular Lens (IOL) - Pipeline Products by Stage of Development
  • Intraocular Lens (IOL) - Pipeline Products by Segment
  • Intraocular Lens (IOL) - Pipeline Products by Territory
  • Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
  • Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
  • Intraocular Lens (IOL) - Ongoing Clinical Trials
  • Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
  • Intraocular Lens (IOL) - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Intraocular Lens (IOL) - Pipeline Products by Stage of Development
  • Intraocular Lens (IOL) - Pipeline Products by Segment
  • Intraocular Lens (IOL) - Pipeline Products by Territory
  • Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
  • Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
  • Intraocular Lens (IOL) - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adaptilens LLC
  • Adoptics AG (Inactive)
  • AkkoLens International BV
  • Alcon Inc
  • Anew Optics, Inc.
  • Atia Vision Inc
  • Bausch & Lomb Inc
  • Care Group
  • CEYEBER Corp
  • Clarvista Medical Inc
  • ClearSight LLC
  • Cord LLC
  • Elenza, Inc.
  • Emmetrope Incorporated
  • EyeKon Medical Inc
  • ForSight Vision6 Inc
  • Gaush Meditech Ltd
  • Henan Universe Intraocular Lens Development Co Ltd
  • Hoya Surgical Optics Inc
  • Innovia LLC
  • Johnson & Johnson Surgical Vision Inc
  • LensGen Inc
  • London Eye Hospital
  • Medicontur Medical Engineering Ltd
  • Meir Medical Center
  • Morcher Gmbh
  • Nayam Innovations Pvt Ltd
  • Nidek Co Ltd
  • Northwestern University
  • NuLens Ltd. (Inactive)
  • Ocumetics Technology Corp
  • PhysIOL SA
  • PowerVision Inc
  • Presbeasy
  • Rayner Intraocular Lenses Ltd
  • Sav-Iol SA
  • Shanghai Haohai Biological Technology Co Ltd
  • STAAR Surgical Company
  • Strathspey Crown LLC
  • Tianjin Century Kangtai Biomedical Engineering Co Ltd
  • Ulsan National Institute of Science and Technology
  • University of East Anglia
  • University of Rochester
  • University of Tampere
  • VA St. Louis Health Care System
  • Visidome Ltd
  • Visioneering Technologies Inc
  • VisusNano Labs
  • Voptica SL
  • VSY Biotechnology BV
  • Washington University in St Louis
  • Xend
  • Xi'an Eyedele Medical Technology Co Ltd
  • Z Lens LLC